141 related articles for article (PubMed ID: 30958748)
1. Re: The Efficacy of Botulinum Toxin A and Sacral Neuromodulation in the Management of Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS), What do we Know? ICI-RS 2017 Think Tank, Bristol.
Wein AJ
J Urol; 2019 Jul; 202(1):40-41. PubMed ID: 30958748
[No Abstract] [Full Text] [Related]
2. The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol.
Rahnama'i MS; Marcelissen T; Apostolidis A; Veit-Rubin N; Schurch B; Cardozo L; Dmochowski R
Neurourol Urodyn; 2018 Jun; 37(S4):S99-S107. PubMed ID: 29363792
[TBL] [Abstract][Full Text] [Related]
3. How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018.
Khullar V; Digesu GA; Veit-Rubin N; Sahai A; Rahnama'i MS; Tarcan T; Chermansky C; Dmochowski R
Neurourol Urodyn; 2019 Dec; 38 Suppl 5():S71-S81. PubMed ID: 31821630
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome.
Dobberfuhl AD
Neurourol Urodyn; 2022 Nov; 41(8):1958-1966. PubMed ID: 35607890
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
6. Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai - India.
Rahnama'i MS; Javan A; Vyas N; Lovasz S; Singh N; Cervigni M; Pandey S; Wyndaele JJ; Taneja R
Anesth Pain Med; 2020 Jun; 10(3):e101848. PubMed ID: 32944561
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
Chiu B; Tai HC; Chung SD; Birder LA
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
[TBL] [Abstract][Full Text] [Related]
8. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Frias B; Silva A; Silva JA; Silva CM; Cruz C; Cruz F; Dinis P
Eur Urol; 2010 Sep; 58(3):360-5. PubMed ID: 20227820
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
Jhang JF; Jiang YH; Kuo HC
Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.
Shim SR; Cho YJ; Shin IS; Kim JH
Int Urol Nephrol; 2016 Aug; 48(8):1215-1227. PubMed ID: 27139498
[TBL] [Abstract][Full Text] [Related]
11. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
Meng E; Hsu YC; Chuang YC
Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
[TBL] [Abstract][Full Text] [Related]
12. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
13. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
14. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
15. Sacral neuromodulation for refractory overactive bladder, interstitial cystitis, and painful bladder syndrome.
Laviana A; Jellison F; Kim JH
Neurosurg Clin N Am; 2014 Jan; 25(1):33-46. PubMed ID: 24262898
[TBL] [Abstract][Full Text] [Related]
16. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
[TBL] [Abstract][Full Text] [Related]
17. [Alternative treatments for interstitial cystitis].
Gamé X; Bart S; Castel-Lacanal E; De Sèze M; Karsenty G; Labat JJ; Rigaud J; Scheiber-Nogueira MC; Ruffion A;
Prog Urol; 2009 Jun; 19(6):357-63. PubMed ID: 19467453
[TBL] [Abstract][Full Text] [Related]
18. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
Dellis A; Papatsoris AG
Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
[TBL] [Abstract][Full Text] [Related]
19. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
Gajewski JB; Al-Zahrani AA
BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
[TBL] [Abstract][Full Text] [Related]
20. What is the Best Treatment Option for Coexisting Pelvic Floor Dysfunctions?
Tutolo M; Ammirati E; Van der Aa F
Eur Urol Focus; 2017 Dec; 3(6):532-534. PubMed ID: 29551556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
